Considering HUMIRA for Hidradenitis Suppurativa?

HUMIRA and Hidradenitis Suppurativa

Humira is used for the treatment of adults and adolescents from 12 years of age with active moderate to severe Hidradenitis Suppurativa (acne inversa) when response to other treatments is inadequate.

Significant results in just 3 months.

HUMIRA was studied in over 600 adult patients like you with Hidradenitis Suppurativa — the largest clinical trials completed for HS to date.

HUMIRA was shown to provide a clinically significant response after 12 weeks of treatment to a substantial proportion of patients (40-60%). Your results may vary.

Humira for HS in New Zealand

HUMIRA is only available on prescription for adults and adolescents from 12 years and older with Hidradenitis Suppurativa. Talk to your Dermatologist or specialist to see if HUMIRA is right for them.

The government medicine funding agency, PHARMAC, fully subsidises HUMIRA for Hidradenitis Suppurativa if they have not fully responded to other medicines prescribed by a specialist, and you meet other criteria required by PHARMAC. Your specialist will discuss whether HUMIRA is right for you, and whether you qualify for PHARMAC funded treatment. Usual doctor’s consultation fees, and pharmacy prescription charges remain payable by you.

HUMIRA Safety Information

Safety information on this website includes some of the more important information to know about HUMIRA.

Read More 

How does HUMIRA work?

HUMIRA is a fully human monoclonal antibody. HUMIRA recognises and binds to a specific protein (tumour necrosis factor or TNF-alpha), which is present at increased levels in inflammatory diseases such as Hidradenitis Suppurativa.

Read More 

Starting and taking HUMIRA

What you need to know about taking HUMIRA, including free support to help you get the best out of your HUMIRA treatment.

Read More